245 related articles for article (PubMed ID: 30176422)
1. Being "hooked up" during a sharp increase in the availability of illicitly manufactured fentanyl: Adaptations of drug using practices among people who use drugs (PWUD) in New York City.
McKnight C; Des Jarlais DC
Int J Drug Policy; 2018 Oct; 60():82-88. PubMed ID: 30176422
[TBL] [Abstract][Full Text] [Related]
2. Examining opioid-involved overdose mortality trends prior to fentanyl: New York City, 2000-2015.
Tuazon E; Kunins HV; Allen B; Paone D
Drug Alcohol Depend; 2019 Dec; 205():107614. PubMed ID: 31689642
[TBL] [Abstract][Full Text] [Related]
3. Preference for drugs containing fentanyl from a cross-sectional survey of people who use illicit opioids in three United States cities.
Morales KB; Park JN; Glick JL; Rouhani S; Green TC; Sherman SG
Drug Alcohol Depend; 2019 Nov; 204():107547. PubMed ID: 31536877
[TBL] [Abstract][Full Text] [Related]
4. Effect of witnessing an overdose on the use of drug checking services among people who use illicit drugs in Vancouver, Canada.
Beaulieu T; Hayashi K; Nosova E; Milloy MJ; DeBeck K; Wood E; Kerr T; Ti L
Am J Drug Alcohol Abuse; 2020 Jul; 46(4):506-511. PubMed ID: 31983241
[TBL] [Abstract][Full Text] [Related]
5. Harm reduction measures employed by people using opioids with suspected fentanyl exposure in Boston, Baltimore, and Providence.
Rouhani S; Park JN; Morales KB; Green TC; Sherman SG
Harm Reduct J; 2019 Jun; 16(1):39. PubMed ID: 31234942
[TBL] [Abstract][Full Text] [Related]
6. Fentanyl test strips as an opioid overdose prevention strategy: Findings from a syringe services program in the Southeastern United States.
Peiper NC; Clarke SD; Vincent LB; Ciccarone D; Kral AH; Zibbell JE
Int J Drug Policy; 2019 Jan; 63():122-128. PubMed ID: 30292493
[TBL] [Abstract][Full Text] [Related]
7. Changes in drug use behaviors coinciding with the emergence of illicit fentanyl among people who use drugs in Vancouver, Canada.
Brar R; Grant C; DeBeck K; Milloy MJ; Fairbairn N; Wood E; Kerr T; Hayashi K
Am J Drug Alcohol Abuse; 2020 Sep; 46(5):625-631. PubMed ID: 32689810
[No Abstract] [Full Text] [Related]
8. Responding to a surge in overdose deaths: perspectives from US syringe services programs.
Frost MC; Austin EJ; Corcorran MA; Briggs ES; Behrends CN; Juarez AM; Frank ND; Healy E; Prohaska SM; LaKosky PA; Kapadia SN; Perlman DC; Schackman BR; Des Jarlais DC; Williams EC; Glick SN
Harm Reduct J; 2022 Jul; 19(1):79. PubMed ID: 35854351
[TBL] [Abstract][Full Text] [Related]
9. Overdose Deaths Involving Fentanyl and Fentanyl Analogs - New York City, 2000-2017.
Colon-Berezin C; Nolan ML; Blachman-Forshay J; Paone D
MMWR Morb Mortal Wkly Rep; 2019 Jan; 68(2):37-40. PubMed ID: 30653482
[TBL] [Abstract][Full Text] [Related]
10. Trends in and Characteristics of Drug Overdose Deaths Involving Illicitly Manufactured Fentanyls - United States, 2019-2020.
O'Donnell J; Tanz LJ; Gladden RM; Davis NL; Bitting J
MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(50):1740-1746. PubMed ID: 34914673
[TBL] [Abstract][Full Text] [Related]
11. Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: A mixed methods study.
Carroll JJ; Marshall BDL; Rich JD; Green TC
Int J Drug Policy; 2017 Aug; 46():136-145. PubMed ID: 28578864
[TBL] [Abstract][Full Text] [Related]
12. The introduction of fentanyl on the US-Mexico border: An ethnographic account triangulated with drug checking data from Tijuana.
Friedman J; Bourgois P; Godvin M; Chavez A; Pacheco L; Segovia LA; Beletsky L; Arredondo J
Int J Drug Policy; 2022 Jun; 104():103678. PubMed ID: 35421740
[TBL] [Abstract][Full Text] [Related]
13. Heroin uncertainties: Exploring users' perceptions of fentanyl-adulterated and -substituted 'heroin'.
Ciccarone D; Ondocsin J; Mars SG
Int J Drug Policy; 2017 Aug; 46():146-155. PubMed ID: 28735775
[TBL] [Abstract][Full Text] [Related]
14. Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: Challenges and innovations responding to a dynamic epidemic.
Fairbairn N; Coffin PO; Walley AY
Int J Drug Policy; 2017 Aug; 46():172-179. PubMed ID: 28687187
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of Fentanyl Overdose - Massachusetts, 2014-2016.
Somerville NJ; O'Donnell J; Gladden RM; Zibbell JE; Green TC; Younkin M; Ruiz S; Babakhanlou-Chase H; Chan M; Callis BP; Kuramoto-Crawford J; Nields HM; Walley AY
MMWR Morb Mortal Wkly Rep; 2017 Apr; 66(14):382-386. PubMed ID: 28406883
[TBL] [Abstract][Full Text] [Related]
16. Knowledge of Fentanyl and Perceived Risk of Overdose Among Persons Who Use Drugs in Vancouver, Canada.
Moallef S; Nosova E; Milloy MJ; DeBeck K; Fairbairn N; Wood E; Kerr T; Hayashi K
Public Health Rep; 2019; 134(4):423-431. PubMed ID: 31211644
[TBL] [Abstract][Full Text] [Related]
17. Understanding intentionality of fentanyl use and drug overdose risk: Findings from a mixed methods study of people who inject drugs in New York City.
McKnight C; Weng CA; Reynoso M; Kimball S; Thompson LM; Jarlais DD
Int J Drug Policy; 2023 Aug; 118():104063. PubMed ID: 37270373
[TBL] [Abstract][Full Text] [Related]
18. Young people who use drugs engaged in harm reduction programs in New York City: Overdose and other risks.
Calvo M; MacFarlane J; Zaccaro H; Curtis M; Cabán M; Favaro J; Passannante MR; Frost T
Drug Alcohol Depend; 2017 Sep; 178():106-114. PubMed ID: 28645060
[TBL] [Abstract][Full Text] [Related]
19. "It wasn't here, and now it is. It's everywhere": fentanyl's rising presence in Oregon's drug supply.
Shin SS; LaForge K; Stack E; Pope J; Leichtling G; Larsen JE; Leahy JM; Seaman A; Hoover D; Chisholm L; Blazes C; Baker R; Byers M; Branson K; Korthuis PT
Harm Reduct J; 2022 Jul; 19(1):76. PubMed ID: 35818072
[TBL] [Abstract][Full Text] [Related]
20. A mixed-methods analysis of risk-reduction strategies adopted by syringe services program participants and non-syringe services program participants in New York City.
Beharie N; Urmanche A; Harocopos A
Harm Reduct J; 2023 Mar; 20(1):38. PubMed ID: 36966342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
